PharmaCyte Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 02/11/2025 | 192,387 | $298,200 | 0.00% | 2.52% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 164,736 | $255,364 | -2.06% | 2.16% |
| EQUITEC PROPRIETARY MARKETS, LLC | 01/29/2025 | 82,727 | $129,881 | 0.00% | 1.08% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 49,300 | $77,401 | -0.80% | 0.65% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 34,481 | $53,446 | -2.12% | 0.45% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 26,841 | $41,603 | -2.75% | 0.35% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 25,700 | $40,349 | -0.77% | 0.34% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 2,445 | $3,839 | -14.51% | 0.03% |
| UBS GROUP AG | 02/14/2025 | 1,874 | $2,942 | -77.57% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 508 | $869 | 0.00% | 0.01% |
| 02/28/2025 | 37 | $58 | 100.00% | 0.00% | |
| JPMORGAN CHASE & CO | 02/12/2025 | 18 | $28 | 0.00% | 0.00% |
| SACHETTA, LLC | 01/21/2025 | 14 | $22 | 0.00% | 0.00% |
| BFSG, LLC | 01/31/2025 | 5 | $8 | 0.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 02/13/2025 | 2 | $3 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| K2 PRINCIPAL FUND, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ASPIRE PRIVATE CAPITAL, LLC | 01/17/2025 | 0 | $0 | -100.00% | 0.00% |
| MARYLAND CAPITAL ADVISORS INC. | 01/30/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
PharmaCyte Biotech, Inc. institutional Ownership - FAQ's
During the previous two years, 26 institutional investors and hedge funds held shares of PharmaCyte Biotech, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 192,387
GEODE CAPITAL MANAGEMENT, LLC: 164,736
EQUITEC PROPRIETARY MARKETS, LLC: 82,727
RENAISSANCE TECHNOLOGIES LLC: 49,300
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 34,481
DIMENSIONAL FUND ADVISORS LP: 26,841
7.86% of PharmaCyte Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 705,912 shares in the last 24 months. This purchase volume represents approximately $1.15 M in transactions.